Evaluation of N-NOSE as a surveillance tool for recurrence in gastric and esophageal cancers: a prospective cohort study
This study suggests the potential of N-NOSE as an effective follow-up tool for patients with upper gastrointestinal cancer, particularly those with vascular invasion. While N-NOSE has been validated to distinguish between cancer and non-cancer, and its performance compared to traditional markers has been proven, it has not been studied for recurrence. Our data highlights, for the first time, the capability of N-NOSE in the surveillance of cancer recurrence.
Authors
- Eric di Luccio (ORCID: https://orcid.org/0000-0002-2256-2157)
- Umbhorn Ungkulpasvich (ORCID: https://orcid.org/0000-0002-9735-3798)
- Takaaki Hirotsu (ORCID: https://orcid.org/0009-0009-3276-6020)
- Tomonori Narita
- Yasuyuki Seto (ORCID: https://orcid.org/0000-0002-6953-8752)
- Hideyuki Hatakeyama
- Koichi Yagi (ORCID: https://orcid.org/0000-0001-8319-8005)
- Akihiro Kuroda
- Masayo Morishita
- Sayuri Iitaka
Institutions
- Tokyo National Hospital (JP)
- The University of Tokyo (JP)
Publication Details
- Journal
- BMC Cancer
- Published
- 2024-12-18
- DOI
- https://doi.org/10.1186/s12885-024-13327-x
- Citations
- 4
- Primary Topic
- Advanced Chemical Sensor Technologies
- Type
- article
- Field-Weighted Citation Impact
- 0.74